Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
May 15 2024 - 7:00AM
Business Wire
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving
health through innovative tests that guide patient care, today
announced that its executive management is scheduled to present a
company overview at the Leerink Partners Healthcare Crossroads
Conference on Wednesday, May 29, 2024, at 2:00 p.m. Eastern
time.
A live audio webcast of the Company’s presentation will be
available by visiting Castle Biosciences’ website at
ir.castlebiosciences.com/events-presentations/. A replay of the
webcast will be available following the conclusion of the live
broadcast.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics
company improving health through innovative tests that guide
patient care. The Company aims to transform disease management by
keeping people first: patients, clinicians, employees and
investors.
Castle’s current portfolio consists of tests for skin cancers,
Barrett’s esophagus, mental health conditions and uveal melanoma.
Additionally, the Company has active research and development
programs for tests in other diseases with high clinical need,
including its test in development to help guide systemic therapy
selection for patients with moderate-to-severe atopic dermatitis,
psoriasis and related conditions. To learn more, please visit
www.CastleBiosciences.com and connect with us on LinkedIn,
Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath
Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM,
DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle
Biosciences, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515189022/en/
Investor Contact: Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact: Allison Marshall
amarshall@castlebiosciences.com
Castle Biosciences (NASDAQ:CSTL)
Historical Stock Chart
From May 2024 to Jun 2024
Castle Biosciences (NASDAQ:CSTL)
Historical Stock Chart
From Jun 2023 to Jun 2024